Canton Strategic Holdings (CNTN) Shareholder's Equity Growth (1y) (2021 - 2026)
Canton Strategic Holdings (CNTN) Shareholder's Equity Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57,767.37% |
| Dec 31, 2025 | 30,330.80% |
| Sep 30, 2025 | 103.97% |
| Jun 30, 2025 | -94.51% |
| Mar 31, 2025 | -111.56% |
| Dec 31, 2024 | -85.68% |
| Sep 30, 2024 | 71.75% |
| Jun 30, 2024 | 118.11% |
| Mar 31, 2024 | 120.24% |
| Dec 31, 2023 | 64.72% |
| Sep 30, 2023 | -75.31% |
| Jun 30, 2023 | -66.05% |
| Mar 31, 2023 | -69.04% |
| Dec 31, 2022 | 218.33% |
| Sep 30, 2022 | 199.60% |
| Jun 30, 2022 | 243.59% |
| Mar 31, 2022 | 295.31% |
| Dec 31, 2021 | -26.02% |